8-K 1 a8-k_021004.txt ITEM 5 OTHER EVENTS AND REGULATION FD DISCLOSURE UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act February 9, 2004 ---------------- Date of Report (Date of Earliest Event Reported) IMAGING DIAGNOSTIC SYSTEMS, INC. ------------------------------------------------------ (Exact name of registrant as specified in its charter) Florida 0-26028 22-2671269 (State or Other Jurisdiction of (Commission File Number) (I.R.S. Employer Incorporation or Organization) Identification Number) 6531 NW 18TH COURT PLANTATION, FL 33313 -------------------------------------------------- (Address of principal executive offices) (954) 581-9800 ----------------------------------------- (Registrant's telephone number) Item 5. Other Events and Regulation FD Disclosure On February 9, 2004, we submitted a response to the warning letter from the FDA regarding the biomonitoring inspection conducted August 13th through August 18th, 2003 at our facility. We are continuing to move forward on the preparation of the supplementary information to support our PMA application. SIGNATURES Pursuant to the requirements of the Securities and Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized. IMAGING DIAGNOSTIC SYSTEMS, INC. Dated February 10, 2004 /s/ Linda B. Grable ------------------- By: Linda B. Grable Chief Executive Officer and Chairman of the Board /s/ Allan L. Schwartz --------------------- By: Allan L. Schwartz Executive Vice President Chief Financial Officer